Trinity Biotech Invests in Novus Diagnostics to Accelerate Rapid Sepsis Testing
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Read MorePosted by Andy Lundin | Nov 27, 2024 | Company News, Sepsis |
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Read MorePosted by Andy Lundin | Nov 19, 2024 | Sexually Transmitted Diseases |
NOWDiagnostics has launched the First To Know Syphilis Test, an FDA-authorized over-the-counter syphilis test in the U.S.
Read MorePosted by Andy Lundin | Nov 19, 2024 | Point-of-Care, Sample Storage & Management |
Fluxergy is collaborating with NIAID to enhance molecular testing and sample preparation on its innovative platform.
Read MorePosted by Chris Wolski | Nov 13, 2024 | Diagnostic Technologies |
For the second year in a row, industry experts predict automation and AI as top clinical laboratory trends in 2025.
Read MorePosted by Andy Lundin | Nov 13, 2024 | Mass Spectrometry Reagents & Test Kits, Point-of-Care |
This collaboration aims to advance a smartphone-based hemoglobin test for accessible diagnostics of anemia and other health conditions.
Read More